
==== Front
CVIR Endovasc
CVIR Endovasc
CVIR Endovascular
2520-8934
Springer International Publishing Cham

39302567
480
10.1186/s42155-024-00480-4
Original Article
Feasibility of an antegrade-retrograde single-sheath inverse technique via vertical puncture in dysfunctional hemodialysis arteriovenous fistula angioplasty
http://orcid.org/0000-0002-2231-5447
Hasegawa Tetsuya te2ya.hase@gmail.com

12
Tsuboi Masahiro 2
Takahashi Yuki 2
Endo Akira 2
Gotoh Yasuo 3
1 grid.518546.b 0000 0004 0604 6771 Department of Diagnostic Radiology, Japanese Red Cross Ishinomaki Hospital, 71, Nishimichishita, Hebita, Ishinomaki-shi, Miyagi 986-8522 Japan
2 https://ror.org/01paha414 grid.459827.5 0000 0004 0641 2751 Department of Diagnostic Radiology, Osaki Citizen Hospital, 3-8-1, Honami, Furukawa, Osaki-shi, Miyagi 989-6183 Japan
3 Department of Radiology, Shunt Clinic Sendai-Higashi, 2-17-25, Higashi Sendai, Miyagino-ku, Sendai-shi, Miyagi 983-0833 Japan
20 9 2024
20 9 2024
12 2024
7 6910 5 2024
5 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Stenosis resulting in dysfunctional dialysis access may occur simultaneously on the anastomotic and central venous side. The purpose of this study was to retrospectively evaluate the feasibility of a single sheath inverse technique using the vertical puncture approach to perform bidirectional transvenous percutaneous transluminal angioplasty (PTA) from a single sheath for such dialysis access stenoses.

Materials and Methods

Twenty patients (26 cases; 13 males; median age, 74 [range: 50–89] years) who underwent PTA using the sheath inverse technique for dysfunctional arteriovenous fistula stenoses between April 2019 and June 2023 were included. All procedures were performed in an outpatient setting. A 4-cm sheath (4Fr, four cases; 5Fr, 19 cases; 6Fr, three cases) was inserted by vertical puncture through a cutaneous vein in the forearm (20 cases) or upper arm (six cases). After treating one side of the lesion, the sheath was reversed to treat the lesion on the opposite side. The vessel diameter at the sheath insertion site, the success rate of sheath inversion, the number of PTA balloon catheters used, the PTA success rate, adverse events, and primary and secondary patency rates up to one year after PTA were evaluated.

Results

The median diameter at the sheath indwelling site was 5.2 (range: 3.6–9.5) mm, and sheath inversion was successful in all cases, eliminating the need to place an additional sheath at another site for contralateral stricture treatment. The number of balloon catheters used was one and two in 17 (65%) and eight cases (31%), respectively, and three in one case wherein a drug-coated balloon was used. PTA was successful in all cases and major complications were not observed. However, in one case wherein a sheath had to be placed at the arterial needle puncture site, the skin was hard, leading to difficulty in inversion, and transient venous spasm occurred post-inversion. The primary patency rates at 3, 6 and 12 months after the PTA were 87.5%, 41.7%, and 20.8%, respectively. The secondary patency rates at 6 and 12 months were 100% and 75%, respectively.

Conclusion

The single-sheath inverse technique for arteriovenous fistulas was feasible without sheath withdrawal.

Graphical Abstract

Supplementary Information

The online version contains supplementary material available at 10.1186/s42155-024-00480-4.

Keywords

PTA
Sheath
Inverse technique
Arteriovenous fistula
Dialysis access
Vascular access
issue-copyright-statement© Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and Springer International Publishing AG 2024
==== Body
pmcBackground

Percutaneous transluminal angioplasty (PTA) remains the first-line treatment for dialysis access stenosis. It is indicated when there is significant stenosis accompanied by clinical dysfunction. Clinical signs of access dysfunction are broadly manifested as inflow obstruction (difficulty in puncturing, inability to achieve adequate dialysis flow rate, and poor fistula maturation) or outflow obstruction (swelling of arm and prolonged bleeding) [1, 2]. The transvenous retrograde approach is commonly used in PTA for stenosis of the arteriovenous fistula (AVF) for dialysis, as most patients have stenosis on the anastomotic side [3–6]. However, when lesions are present both upstream (anastomosis side) and downstream (heart side) of the approach site, the two sheaths may need to be inserted in opposite directions. According to the Japanese Society of Interventional Radiology guidelines for basic techniques of vascular access interventional therapy, “In cases of difficulty to insert two sheaths, it can be possible that one sheath is inverted oppositely using a guidewire” [7]. However, to the best of our knowledge, this detailed, single-sheath inverse technique has rarely been reported in the literature. Therefore, in this study, we aimed to retrospectively evaluate the feasibility of the single-sheath inverse technique using a vertical puncture approach in PTA for AVF stenosis for dialysis.

Methods

This is a retrospective observational study conducted at a single institution. All procedures were performed in accordance with the ethical standards of our institutional research committee. The study was approved by our Institutional Review Board (approval number: 20240325–53), and all patients provided written informed consent to undergo the procedure.

PTA procedures for AVF stenosis and occlusion are typically performed on an outpatient basis. Therefore, the transvenous approach is prioritized. The puncture site is chosen by the operator based on the most feasible location, determined through pre-procedural ultrasonography. Specifically, sites with a longer intact section and where the vessel diameter is relatively preserved are selected. If the examination, ultrasound findings, and dialysis indicators (such as increased venous pressure or upper limb edema) indicate stenoses on both sides of the sheath insertion site or if stenosis is suspected, the sheath may be reversed. Therefore, the puncture is performed vertically.

Patients

Between April 2019 and June 2023, 20 patients (13 males and 7 females; median age [range], 74 [50–89] years) underwent 26 PTA procedures for AVF stenosis using the single-sheath inverse technique (Table 1). The median number of past PTA performed until this intervention was 3 (range, 1–9). All patients were referred to our outpatient department and had reduced blood flow for dialysis, as well as at least one of the following symptoms: upper limb edema, prolonged hemostasis time, or increased venous pressure. Patients with arteriovenous grafts were excluded. In cases of thrombosed occluded AVF, there were no cases with stenosis downstream (toward the heart) from the sheath insertion site; thus coincidentally, they were not included in this study. Before inserting the sheath, ultrasonography was performed to observe stenosis on the anastomotic side. The properties of the sheath insertion site, including its diameter, were evaluated in all but two cases. The sheath insertion sites were the cephalic vein of the forearm in 19 cases (73%), cephalic vein of the upper arm in six cases (23%), and ulnar vein of the forearm in one case (4%) of ulnobasilic AVF. Table 1 Details of PTA using the single-sheath inverse technique in 26 cases

Patient Characteristics	N = 20 patients		
Median age (range)	74 (50–89) y		
Sex (Male: Female)	13: 7	65%: 35%	
Median number of past PTA (range)	3 (1–9) times		
AVF type	
 Radiocephalic AVF	15	75%	
 Brachiocephalic AVF	4	20%	
 Ulnobasilic AVF	1	5%	
Summary of cases	N = 26 cases		
Sheath insertion site	
 Cephalic vein of the forearm	19	73%	
 Cephalic vein of the upper arm	6	23%	
 Ulnar vein of the forearm	1	4%	
Size of sheath used	
 4 Fr	4	15%	
 5 Fr	19	73%	
 6 Fr	3	12%	
Median venous diameter at the sheath placement site (range)	5.2 (3.6–9.5) mm		
Sheath inverse success	26	100%	
Number of balloon catheters used	
 One	17	65%	
 Two	8	31%	
 Three	1a	4%	
PTA success	26	100%	
Major complication	0		
Minor complication	1b	4%	
Primary and secondary patency rates in 24 cases	(primary; secondary)		
 3 months	87.5%; 100%		
 6 months	41.7%; 100%		
 1 year	20.8%; 75%c		
AVF arteriovenous fistula

aUse of drug-coated balloons

bTransient venous spasm occurred

csurgical reconstruction: 3, death: 2, tunneled cuffed catheter: 1

Procedures

A 4-cm sheath (Radifocus introducer; Terumo Co., Tokyo, Japan) was inserted in 26 cases (4Fr, n = 4; 5Fr, n = 19; 6Fr, n = 3) using the vertical puncture approach with the Seldinger technique. The vertical puncture approach involved perpendicularly puncturing the skin with an 18G needle; after confirming the backflow of blood into the inner hub, the needle was tilted to one side (Fig. 1). First, a sheath was inserted toward one side, and balloon angioplasty was performed for the stenosis. Next, the sheath was reversed to treat the lesion on the opposite side using the same or a different balloon catheter. Balloon catheters with diameters ranging from 3 to 8 mm were used. In one case, after sheath inversion, the sheath was changed to 6Fr to allow the use of a larger balloon. There are two main methods for inverting the sheath using a dilator and a guidewire attached to the sheath introducer set: with and without fluoroscopy.Fig. 1 Schema of the vertical puncture approach. a First, the skin and cutaneous vein were perpendicularly punctured using an 18-gauge needle. b, c After confirming the backflow of blood into the inner hub, the needle was tilted to one side. d Finally, a suitably sized sheath was inserted using the Seldginger technique

Without fluoroscopy: The dilator and the short guidewire provided with the sheath introducer set are loaded into the sheath and allowed to remain within the sheath’s tip to prevent the sheath from kinking. As the sheath tip slightly traces the posterior wall of the vessel with minimal resistance, the sheath is slowly retracted and erected. When the sheath stands vertically, the guidewire is advanced into the opposite vein. Subsequently, the dilator is advanced from the tip of the sheath, followed by advancing the sheath over the guidewire (Fig. 2).

Fig. 2 Schematic and sequential images demonstrating the sheath inverse technique without fluoroscopy. a-f First, the dilator and guidewire were loaded into the sheath to ensure that they remained within the sheath's tip, preventing kinking of the sheath and facilitating the rapid use of the guidewire post-inversion. b-g The sheath was then carefully withdrawn in a vertical direction along with the dilator and guidewire, encountering some resistance. c-h The sheath was slightly inversed, and the guidewire advanced to the opposite side, ensuring smooth progression without resistance. d-i The dilator was advanced to emerge from the sheath’s tip, and the sheath was then advanced with the dilator over the guidewire. e-j Upon adequate sheath insertion, the guidewire and dilator were removed

b) Under fluoroscopy: Similar to method (a), the dilator is loaded into the sheath tip to prevent sheath kinking. In this method, the 0.035” short guidewire attached to the sheath introducer is set slightly protruding from the sheath tip. Then, the sheath is pulled slowly to the vertical position, and traced along the posterior wall of the vessel with slight resistance under fluoroscopy. The guidewire is sufficiently advanced deep into the opposite vein, and its progression is confirmed with fluoroscopy. Subsequently, the dilator is advanced from the tip of the sheath, followed by the sheath itself, as described in method (a) (Figs 3 and 4).

Fig. 3 Fluoroscopy-assisted demonstration of the sheath inverse technique. a The dilator was loaded into the sheath to prevent it from protruding beyond the tip; this was followed by pulling out the sheath under fluoroscopy while maintaining visualization of the blood vessel with the guidewire. b, c The opposite side was selected using the guidewire while ensuring the sheath was in a near-vertical position. Upon sufficient advancement of the guidewire, we proceeded to advance and position the dilator and sheath accordingly

Fig. 4 Case presentation of a male patient in his 50 s with a left brachiocephalic arteriovenous fistula (AVF). The patient presented with complaints of low blood flow quantity and prolonged hemostasis time at the arterial needle puncture site. The vessel diameter at the sheath insertion site was φ3.6 mm. a A 4Fr sheath was placed facing the anastomotic side, followed by antegrade angiography from the brachial artery using a 4Fr short catheter to confirm severe stenoses at the anastomotic side and the opposite side of the sheath (indicated by arrows). b c Dilation of the severe stenosis on the anastomotic side using a 5 mm × 40 mm high-pressure balloon catheter (BRAVUS, Boston Scientific, Natick, Massachusetts). d Retrograde angiography from the sheath confirmed the resolution of the severe stenosis on the anastomotic side. e Confirmation of residual stenosis on the opposite side after sheath inverse technique through antegrade angiography. f Dilation of the residual stenosis using the same balloon catheter. g Verification of the resolution of the severe stenosis

Outcome points

The evaluation items were the vessel diameter at the sheath insertion site, the success rate of the sheath inverse technique, the number of PTA balloon catheters used, the PTA success rate, and adverse events. In addition, primary and secondary patency rates at 3 months, 6 months, and one year after the PTA were evaluated. The diameters of the blood vessels at the sheath insertion site were measured using ultrasonography without using a tourniquet. Successful sheath inverse was defined as reversal without sheath withdrawal. PTA success was defined as technical residual stenosis of < 30% and the clinical ability to provide at least one session of adequate dialysis after percutaneous intervention [8, 9]. Adverse events were evaluated using the CIRSE classification system [10]. After excluding two cases lost to follow-up immediately after PTA, the patency rates were evaluated in 24 cases. Primary patency was defined as patency during the interval between the PTA using single-sheath inverse technique and the next repeated radiologic intervention for dysfunction in dialysis access. Secondary patency was defined as patency during the interval between the PTA and the occurrence of any of the following events: surgical revision or reconstruction of the fistula, tunneled cuffed catheter placement, or death. Multiple treatments including angioplasty and thrombectomy may be included in secondary patency [11].

Results

The median venous diameter at the sheath placement site was 5.2 (range: 3.6–9.5) mm. Sheath inverse was successful in all 26 cases. The number of balloon catheters was one in 17 cases (65%), and two in eight cases (31%). Three balloons were used in one case (4%) using a drug-coated balloon catheter. PTA was successful in all cases. In all cases, we confirmed a reduction in the manual increase in venous pressure from the sheath after PTA, and there was no difficulty in achieving hemostasis at the sheath placement site. Although no major complications were observed, there was one case of temporary venous spasm after the sheath inverse technique. In this case, the sheath needed to be placed at the arterial needle puncture site; however, the skin at this site was hard due to the presence of scar tissue, leading to difficulty in inversion (Fig. 5). The primary patency rates at 3 months, 6 months and 1 year after the PTA were 87.5% (21/24), 41.7% (10/24), and 20.8% (5/24), respectively. The secondary patency rates at 3 months, 6 months and 1 year after the PTA were 100%, 100%, and 75% (18/24), respectively. The results are summarized in Table 1, while case details including clinical course post-PTA are shown in Supplemental Table 1.Fig. 5 Case study of a male patient in his 70 s with a left radiocephalic arteriovenous fistula (AVF). The patient presented with swelling of the vascular access limb and low blood flow quantity. The vessel diameter at the sheath insertion site was φ4.7 mm. a Placement of a 5Fr sheath facing the heart side, followed by antegrade angiography revealing severe stenosis of the subclavian vein (indicated by arrows). b Prior to the sheath inverse technique, retrograde angiography demonstrated slight visualization of the stenosis on the anastomotic side (indicated by arrows) using a tourniquet. c First, the subclavian venous stenosis was dilated using a Φ6 mm × 40 mm balloon catheter (Ultraverse035; Becton Dickinson, Franklin Lakes, NJ, USA), resulting in stenosis reduction. d After sheath inversion, the stenosis of the forearm cephalic vein was dilated using a Φ5 mm × 40 mm balloon catheter (DORADO; Becton Dickinson), resolving the issue. e However, a transient spasm—presumed to be a result of the sheath inverse technique—occurred at the site of inversion (indicated by arrowhead), where no stenosis was observed before inversion. f The cephalic vein ran deeply throughout the patient, with swelling of the AVF limb due to downstream venous (central vein) stenosis. The arterial needle puncture site was the only easily accessible site, which had scars formed by frequent dialysis punctures. g The next PTA was performed 182 days later for treatment of insufficient blood flow. Severe restenosis was observed in the cephalic vein near the anastomosis before balloon dilatation image (arrows). There was no stenosis in the spasm site of the previous sheath reversal (arrowhead)

Discussion

Juxta anastomosis, defined as the initial 5 cm of the AVF starting at the arterial-venous anastomosis, is the most common location of stenosis in the venous segments in native AVF for dialysis [3–6, 12, 13]. In contrast, the central vein consists of the subclavian vein, brachiocephalic vein (previously called the innominate vein), or superior vena cava, and the cephalic arch can cause AVF stenosis [3, 5, 12, 14–16]. Although rare, both sites may be stenosed [4, 17]. Dilating both stenoses usually requires placing two sheaths in opposite directions or performing an anterograde angioplasty via brachial arterial access [18].

The single-sheath inverse technique is occasionally used by experienced PTA operators for hemodialysis access trouble, whether AVF or arteriovenous graft. The sheath inverse technique is not difficult to perform. However, there are only two case reports of the sheath inverse technique [17, 19], and only one case of PTA for hemodialysis access [17]. Takashima et al. [17] stated that the advantages are “pain reduction, shortened operation time, and cost-savings.” However, there are no detailed descriptions of these technical aspects. In this study, sheath inverse was possible without the withdrawal of a median vessel diameter of approximately 5 mm.

If a sheath were placed from the radial artery, all stenoses could be eliminated by antegrade access with a single sheath without sheath inversion. However, because PTA is performed on an outpatient basis, transvenous access is preferred to reduce the risk of complications such as hematoma at the puncture site. In addition, it is difficult to place a 6Fr sheath for transarterial access on an outpatient basis safely.

However, one patient experienced temporary venous spasms, which may have been due to sheath inverse. In this case, the cephalic vein was generally deep throughout the body. In addition, the upper limb on the hemodialysis access side was swollen due to severe stenosis of the subclavian vein. Therefore, the arterial needle puncture site was the only easy puncture site. However, the inversion of the sheath was not smooth owing to scarring caused by frequent punctures for dialysis (Fig. 5). In areas with skin hardness, such as scarring, it may be better to avoid sheath inverse.

According to a recent review article by Ratnam et al. [2], primary patency of the target lesion at 6 and 12 months was 42–63% and 23–50.5%, respectively [3, 20–22]. In the present study, the primary patency rate was 41.7% at 6 months and 20.8% at 12 months, which are not extremely low compared to those of previous reports, even though our cases had a history of multiple PTAs and conditions were not favorable. We believe this indicates that the sheath reversal method does not cause excessively poor patency rates.

Limitations include the fact that this was a retrospective study with a small number of patients at a single institution; additionally, the depth of the blood vessel at the sheath insertion site and length of the intact portion were not evaluated, and the skin firmness was not rated.

In conclusion, a sheath-inverse PTA technique for AVF for hemodialysis access is feasible without withdrawal.

Supplementary Information

Supplementary Material 1.

Abbreviations

AVF Arteriovenous fistula

PTA Percutaneous transluminal angioplasty

IRB Institutional Review Board

Acknowledgements

We thank Editage (www.editage.com) for English language editing.

Authors’ contributions

All authors contributed to the conception and design of this study. TH, MT, and YT performed material preparation, data collection, and analysis. TH wrote the first draft of the manuscript, and all authors commented on the previous versions of the paper. All authors have read and approved the final version of the manuscript.

Funding

This study was not supported by any funding agencies.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on request.

Declarations

Ethics approval and consent to participate

All procedures involving human participants performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. This study was approved by the Institutional Review Board.

Consent for publication

Consent for publication was obtained from all individuals included in the study.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Lok CE Huber TS Lee T Shenoy S Yevzlin AS Abreo K KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update Am J Kidney Dis 2020 75 S1 164 10.1053/j.ajkd.2019.12.001 32778223
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020;75:S1-164.32778223
2. Ratnam L Karunanithy N Mailli L Diamantopoulos A Morgan RA Dialysis Access Maintenance: Plain Balloon Angioplasty Cardiovasc Intervent Radiol 2023 46 1136 1143 10.1007/s00270-023-03441-x 37156943
Ratnam L, Karunanithy N, Mailli L, Diamantopoulos A, Morgan RA. Dialysis Access Maintenance: Plain Balloon Angioplasty. Cardiovasc Intervent Radiol. 2023;46:1136–43.37156943
3. Rajan DK Bunston S Misra S Pinto R Lok CE Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty—Are there clinical predictors of patency? Radiology 2004 232 508 515 10.1148/radiol.2322030714 15286321
Rajan DK, Bunston S, Misra S, Pinto R, Lok CE. Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty—Are there clinical predictors of patency? Radiology. 2004;232:508–15.15286321
4. Asif A Gadalean FN Merrill D Cherla G Cipleu CD Epstein DL Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study Kidney Int 2005 67 1986 1992 10.1111/j.1523-1755.2005.00299.x 15840048
Asif A, Gadalean FN, Merrill D, Cherla G, Cipleu CD, Epstein DL, et al. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. Kidney Int. 2005;67:1986–92.15840048
5. Nassar GM Nguyen B Rhee E Achkar K Endovascular treatment of the “failing to mature” arteriovenous fistula Clin J Am Soc Nephrol 2006 1 275 280 10.2215/CJN.00360705 17699217
Nassar GM, Nguyen B, Rhee E, Achkar K. Endovascular treatment of the “failing to mature” arteriovenous fistula. Clin J Am Soc Nephrol. 2006;1:275–80.17699217
6. Robbin ML Greene T Allon M Dember LM Imrey PB Cheung AK Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements: findings from the hemodialysis fistula maturation study J Am Soc Nephrol 2018 29 2735 2744 10.1681/ASN.2017111225 30309898
Robbin ML, Greene T, Allon M, Dember LM, Imrey PB, Cheung AK, et al. Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements: findings from the hemodialysis fistula maturation study. J Am Soc Nephrol. 2018;29:2735–44.30309898
7. Matsuura K Gotoh Y Sadaoka S Takase K Narimatsu Y Guidelines for basic techniques in vascular access intervention therapy (VAIVT) Intervent Radiol 2018 3 28 43 10.22575/interventionalradiology.3-1G2
Matsuura K, Gotoh Y, Sadaoka S, Takase K, Narimatsu Y. Guidelines for basic techniques in vascular access intervention therapy (VAIVT). Intervent Radiol. 2018;3:28–43.
8. Aktas A Bozkurt A Aktas B Kirbas I Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency Diagn Interv Radiol 2015 21 160 166 10.5152/dir.2014.14348 25698092
Aktas A, Bozkurt A, Aktas B, Kirbas I. Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency. Diagn Interv Radiol. 2015;21:160–6.25698092
9. Dariushnia SR Walker TG Silberzweig JE Annamalai G Krishnamurthy V Mitchell JW Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit J Vasc Interv Radiol 2016 27 1518 1530 10.1016/j.jvir.2016.07.015 27622727
Dariushnia SR, Walker TG, Silberzweig JE, Annamalai G, Krishnamurthy V, Mitchell JW, et al. Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit. J Vasc Interv Radiol. 2016;27:1518–30.27622727
10. Filippiadis DK Binkert C Pellerin O Hoffmann RT Krajina A Pereira PL Cirse quality assurance document and standards for classification of complications: the cirse classification system Cardiovasc Intervent Radiol 2017 40 1141 1146 10.1007/s00270-017-1703-4 28584945
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6.28584945
11. Gray RJ Sacks D Martin LG Trerotola SO Society of Interventional Radiology Technology Assessment Committee. Reporting standards for percutaneous interventions in dialysis access J Vasc Interv Radiol. 2003 14 S433 42 10.1097/01.RVI.0000094618.61428.58 14514859
Gray RJ, Sacks D, Martin LG, Trerotola SO. Society of Interventional Radiology Technology Assessment Committee. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003;14:S433-42.14514859
12. Lookstein RA Haruguchi H Ouriel K Weinberg I Lei L Cihlar S Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas N Engl J Med 2020 383 733 742 10.1056/NEJMoa1914617 32813949
Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383:733–42.32813949
13. Yang CY Li MC Lan CW Lee WJ Lee CJ Wu CH The anastomotic angle of hemodialysis arteriovenous fistula is associated with flow disturbance at the venous stenosis location on angiography Front Bioeng Biotechnol 2020 8 846 10.3389/fbioe.2020.00846 32793578
Yang CY, Li MC, Lan CW, Lee WJ, Lee CJ, Wu CH, et al. The anastomotic angle of hemodialysis arteriovenous fistula is associated with flow disturbance at the venous stenosis location on angiography. Front Bioeng Biotechnol. 2020;8:846.32793578
14. Trerotola SO Kothari S Sammarco TE Chittams JL Central venous stenosis is more often symptomatic in hemodialysis patients with grafts compared with fistulas J Vasc Interv Radiol 2015 26 240 246 10.1016/j.jvir.2014.10.048 25534637
Trerotola SO, Kothari S, Sammarco TE, Chittams JL. Central venous stenosis is more often symptomatic in hemodialysis patients with grafts compared with fistulas. J Vasc Interv Radiol. 2015;26:240–6.25534637
15. Adwaney A Lim C Blakey S Duncan N Ashby DR Central venous stenosis, access outcome and survival in patients undergoing maintenance hemodialysis Clin J Am Soc Nephrol 2019 14 378 384 10.2215/CJN.07010618 30765534
Adwaney A, Lim C, Blakey S, Duncan N, Ashby DR. Central venous stenosis, access outcome and survival in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. 2019;14:378–84.30765534
16. Agarwal AK Patel BM Haddad NJ Central vein stenosis: a nephrologist’s perspective Semin Dial 2007 20 53 62 10.1111/j.1525-139X.2007.00242.x 17244123
Agarwal AK, Patel BM, Haddad NJ. Central vein stenosis: a nephrologist’s perspective. Semin Dial. 2007;20:53–62.17244123
17. Takashima T Nonaka Y Nakashima Y Nonaka E Ikeda Y Fukuda M A one-sheath inverse method in vascular access intervention therapy for hemodialysis patients Int J Surg Case Rep 2019 54 95 98 10.1016/j.ijscr.2018.11.067 30572245
Takashima T, Nonaka Y, Nakashima Y, Nonaka E, Ikeda Y, Fukuda M, et al. A one-sheath inverse method in vascular access intervention therapy for hemodialysis patients. Int J Surg Case Rep. 2019;54:95–8.30572245
18. Manninen HI Kaukanen ET Ikäheimo R Karhapää P Lahtinen T Matsi P Brachial arterial access: endovascular treatment of failing brescia-cimino hemodialysis fistulas—Initial success and long-term results Radiology 2001 218 711 718 10.1148/radiology.218.3.r01mr38711 11230644
Manninen HI, Kaukanen ET, Ikäheimo R, Karhapää P, Lahtinen T, Matsi P, et al. Brachial arterial access: endovascular treatment of failing brescia-cimino hemodialysis fistulas—Initial success and long-term results. Radiology. 2001;218:711–8.11230644
19. Kamada H Ota H Seiji K Takase K Embolization of a paraumbilical shunt by the transparaumbilical venous approach and one-sheath inverse method: a case report Radiol Case Rep 2020 15 2125 2128 10.1016/j.radcr.2020.08.030 32944111
Kamada H, Ota H, Seiji K, Takase K. Embolization of a paraumbilical shunt by the transparaumbilical venous approach and one-sheath inverse method: a case report. Radiol Case Rep. 2020;15:2125–8.32944111
20. Turmel-Rodrigues L Pengloan J Rodrigue H Brillet G Lataste A Pierre D Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology Kidney Int 2000 57 1124 1140 10.1046/j.1523-1755.2000.00940.x 10720965
Turmel-Rodrigues L, Pengloan J, Rodrigue H, Brillet G, Lataste A, Pierre D, et al. Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int. 2000;57:1124–40.10720965
21. Clark TWI Hirsch DA Jindal KJ Veugelers PJ LeBlanc J Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas J Vasc Interv Radiol 2002 13 51 59 10.1016/S1051-0443(07)60009-8 11788695
Clark TWI, Hirsch DA, Jindal KJ, Veugelers PJ, LeBlanc J. Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol. 2002;13:51–9.11788695
22. Rajan DK Clark TWI Patency of Wallstents placed at the venous anastomosis of dialysis grafts for salvage of angioplasty-induced rupture Cardiovasc Intervent Radiol 2003 26 242 245 10.1007/s00270-003-2706-x 14562971
Rajan DK, Clark TWI. Patency of Wallstents placed at the venous anastomosis of dialysis grafts for salvage of angioplasty-induced rupture. Cardiovasc Intervent Radiol. 2003;26:242–5.14562971
